[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-359508-105":59,"doc-detail-359508-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","hypertension-associated-with-the-risk-of-extrahepatic-cancers-in-the-metabolic-dysfunction-associated-steatotic-liver-disease-population-a-multicenter-cross-sectional-study-in-china","Hypertension Associated with the Risk of Extrahepatic Cancers in the Metabolic Dysfunction-associated Steatotic Liver Disease Population - A Multicenter Cross-sectional Study in China","","Extrahepatic cancers represent a key adverse outcome in metabolic dysfunction–associated steatotic liver disease (MASLD), especially in people with cardiometabolic risk factors such as hypertension. This multicenter cross-sectional study evaluated associations among hypertension, liver fibrosis, and extrahepatic cancers within a large MASLD cohort from hospital-based databases across 11 Chinese centers. Logistic regression estimated odds ratios for hypertension alone and combined metabolic conditions, alongside fibrosis measures including FIB-4.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/hypertension-associated-with-the-risk-of-extrahepatic-cancers-in-the-metabolic-dysfunction-associated-steatotic-liver-disease-population-a-multicenter-cross-sectional-study-in-china/359508/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/hypertension-associated-with-the-risk-of-extrahepatic-cancers-in-the-metabolic-dysfunction-associated-steatotic-liver-disease-population-a-multicenter-cross-sectional-study-in-china/359508.png","ImageObject",300,407,{"name":92,"@type":93},"Kyle","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-08","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the primary objective of the study?","Question",{"text":112,"@type":113},"To investigate the association between hypertension, liver fibrosis, and extrahepatic cancers in the MASLD population.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the association between hypertension and extrahepatic cancers quantified?",{"text":117,"@type":113},"Logistic regression estimated odds ratios and 95% confidence intervals for hypertension and related cardiometabolic factors.",{"name":119,"@type":110,"acceptedAnswer":120},"Which fibrosis measure showed an association with extrahepatic cancers?",{"text":121,"@type":113},"After adjusting for confounders, the fibrosis-4 (FIB-4) score was associated with extrahepatic cancers, including within the hypertension subgroup.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},359508,1790458062,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},3985741905716,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Journal of Clinical and Translational Hepatology 2026 vol. 14(3) | 280–290 DOI: 10. 14218/JCTH.2025.00423  \nOriginal Article  \nHypertension Associated with the Risk of Extrahepatic Cancers in the Metabolic Dysfunction-associated Steatotic Liver Disease Population: A Multicenter Cross-sectional Study in China  \nXinyue Zhao1, Feng Xue1,2, Shanshan Wang3, Haiyun Ding3, Dong Li4, Huiying Rao5, Fanpu Ji6, Jidong Jia7, Xiong Ma8, Peng Hu9, Xiaoguang Dou10, Keshu Xu11, Shuangqing Gao3*, Ming Yang1,12* and Lai Wei1*  \n1Hepato-pancreato-biliary Center, Beijing Tsinghua Changgung Hospital, Key Laboratory of Digital Intelligence Hepatology (Ministry of Education), School of Clinical Medicine, Tsinghua Medicine, Tsinghua University, Beijing, China; 2Binzhou Medical University Hospital, Binzhou, Shandong, China; 3Beijing North Medical & Health Economic Research Center, Beijing, China; 4Department of Medical Data Science Center, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University, Beijing, China; 5Peking University People's Hospital, Peking University Hepatology Institute, Beijing, China; 6Department of Hepatology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China; 7Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China; 8Division of Gastroenterology and Hepatology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China; 9Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China; 10Department of Infectious Diseases, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China; 11Department of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China; 12Hubei Shizhen Laboratory, Wuhan, Hubei, China  \nReceived: August 18, 2025 | Revised: January 12, 2026 | Accepted: January 19, 2026 | Published online: March 05, 2026  \nAbstract  \nBackground and Aims: Extrahepatic cancers have been recognized as a significant outcome of metabolic dysfunction–associated steatotic liver disease (MASLD), which involves five cardiometabolic risk factors, including hypertension, and is associated with the tumorigenesis of several cancers or with anti-cancer treatment. We aimed to investigate the association between hypertension, liver fibrosis, and extrahepatic cancers in the MASLD population. Methods: This multicenter cross-sectional study was based on a MASLD population from hospital-based databases across 11 centers nationwide in China, according to MASLD diagnostic criteria identified using keywords and ICD-10 codes. Logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for the association be-  \nKeywords: Metabolic dysfunction–associated steatotic liver disease; MASLD; Extrahepatic cancer/malignancy; Cardiometabolic risk factor; Hypertension; Liver fibrosis.  \n*Correspondence to: Lai Wei, Hepato-pancreato-biliary Center, Beijing Tsinghua Changgung Hospital, Key Laboratory of Digital Intelligence Hepatology (Ministry of Education), School of Clinical Medicine, Tsinghua Medicine, Tsinghua University, 168 Lintang Road, Changping District, Beijing 102218, China. ORCID: [https://](https://)[ ](https://)[orcid.org/0000-0001-7519-627X. Tel:](orcid.org/0000-0001-7519-627X. Tel:) +86-10-56118881, E-mail: weilai@mail. [tsinghua.edu.cn](tsinghua.edu.cn); Shuangqing Gao, Beijing North Medical & Health Economic Research Center, Beijing 100021, China. Tel: +86-10-87953090, E-mail: ga[osq@mherc.org](osq@mherc.org); Ming Yang, Hepato-pancreato-biliary Center, Beijing Tsinghua Changgung Hospital, Key Laboratory of Digital Intelligence Hepatology (Ministry of Education), School of Clinical Medicine, Tsinghua Medicine, Tsinghua University, 168 Lintang Road, Changping District, Beijing 102218, China. ORCID: [https://","cbCaiiCyE7oI7irL","https://ap.wps.com/l/cbCaiiCyE7oI7irL","pdf",2665221,11,"English","# Background and Aims\n# Methods\n# Results\n# Conclusions","[{\"question\":\"What was the primary objective of the study?\",\"answer\":\"To investigate the association between hypertension, liver fibrosis, and extrahepatic cancers in the MASLD population.\"},{\"question\":\"How was the association between hypertension and extrahepatic cancers quantified?\",\"answer\":\"Logistic regression estimated odds ratios and 95% confidence intervals for hypertension and related cardiometabolic factors.\"},{\"question\":\"Which fibrosis measure showed an association with extrahepatic cancers?\",\"answer\":\"After adjusting for confounders, the fibrosis-4 (FIB-4) score was associated with extrahepatic cancers, including within the hypertension subgroup.\"}]","Hypertension Associated with the Risk of Extrahepatic Cancers in the Metabolic Dysfunction-associated Steatotic Liver Disease Population - A Multicenter Cross-sectional Study in China | PDF",1790137067,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8ae388251f0a5a9deae96f730f4a33db.webp",983,1324,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/372996092b6c7c475905449b6240ff27.webp",982,1323,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/20ff3352e9cb0cbb9e8bc026e611c7ca.webp",981,1321,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3975adfb4046677646c63e0ff47db24c.webp",980,1320]